The Class 2A and 3A Top Times Indoor State Championship meets were held in Bloomington Saturday afternoon. Highlights include ...

It only took four seconds for the top ranked team in boys class 2A, Texico, to score in its semifinal round against No. 4 Pecos. The Wolverines never looked back and won 55-43. Texico was able to ...

In just their second year of existence and first in the South Carolina High School League, the Atlantic Collegiate Academy Armada boys basketball program won the Class 2A state title on Saturday, ...

CHAMPAIGN, Ill. (WMBD/WYZZ) — The Manual Rams will bring a fourth-place trophy back to Peoria from the IHSA boys basketball tournament. Chicago Christ the King beat Manual, 55-44, in the class 2A ...

Completed dosing of first two cohorts in Phase 1/2a REWRITE Clinical Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD); Interim ...

We are excited to welcome Dr. Vincent, whose extensive drug development experience and expertise in translating groundbreaking science into therapies will be instrumental in leading our scientific ...

UCB, a global biopharmaceutical company, today announced it will present 8 scientific abstracts, including 3 late-breaker oral presentations, highlighting key data from its innovative ...

Northwestern Lehigh beat Palisades in last year’s Colonial League softball title game and figure to be the top two teams ...

Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

Immuneering is a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients. The Company’s lead product candidate, IMM-1-104 ...

Korro intends to use its Investor Relations website, LinkedIn, and X (Twitter) as means of disclosing material ... 1/2a REWRITE clinical trial; KRRO-110’s potential to treat both liver and lung ...

The developer of a spray-based erectile dysfunctional treatment, LTR Pharma has found a pre-approval route to the US market.